In vitro basophil activation is reduced by short-term omalizumab treatment in hydrolyzed wheat protein allergy.
Chinuki Y, Yagami A, Adachi A, Matsunaga K, Ugajin T, Yokozeki H, Hayashi M, Katayama I, Kohno K, Shiwaku K, Morita E.
Chinuki Y, et al. Among authors: ugajin t.
Allergol Int. 2020 Apr;69(2):284-286. doi: 10.1016/j.alit.2019.09.006. Epub 2019 Nov 18.
Allergol Int. 2020.
PMID: 31753713
Free article.
Clinical Trial.
No abstract available.